Syneron Bio

Company Deals

Syneron Bio Collaborates with AstraZeneca to Develop Macrocyclic Peptides for Chronic Diseases

Fineline Cube Mar 24, 2025

China-based Syneron Bio, a biotech firm specializing in macrocyclic peptide drugs, has entered into a...

Company Drug

Shionogi Submits Rolling NDA for Ensitrelvir in US for COVID-19 Prophylaxis

Policy / Regulatory

China’s National Health Commission Outlines Key Tasks for Primary Healthcare Reform in 2025

Company Drug

Pfizer Expands Abrysvo RSV Vaccine Indication to Include Ages 18-59 in EU

Company Drug Legal / IP

AccurEdit’s ARTbase-A1 Base Editor Authorized by USPTO